We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Polymer Technology Expands 3-D Microarry Surfaces

By Biotechdaily staff writers
Posted on 15 Nov 2002
New reverse phase polymerization technology offers the ability to control and optomize each key attibute of a microarray surface, including density, diffusivity, and uniformity. More...


The quality of the slide coating determines the quality of the data ultimately obtainable from the array. This polymer surface technology provides for unparalleled sensitivity and dynamic range, says STS Biopolymers (Henrietta, NY, USA), which developed the technology. With current 2-D microarray technology, the restricted density of the probe reactive groups and the surface non-uniformity on the slide surface limit assay performance. Recently developed 3-D microarray surfaces provide for higher probe density but the cross-linking of polymers restricts surface diffusivity and target binding.

STS Biopolymers' Graft-Coat technology provides a 3-D surface without cross-linking, capturing all of the advantages without the disadvantages encountered by earlier technologies. Each polymer chain, which is covalently bound to the slide surface, contains structural modifiers to stabilize the graft and to permit complete control over the hydrogel microenvironments.

"This technology can be used with any application, including genomics, proteomics, drug discovery, diagnostics, and chemical synthesis. This control ensures that the surface-bound capture molecules are accessible and present at the concentration desired for each particular application,” said Dr. Michale Violante, vice president of STS Biopolymers.




Related Links:
STS Biopolymers

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Thyroid Test
Anti-Thyroid EIA Test
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.